Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expression

International Journal of Cancer

Volumn 62, Issue 1, 1995, Pages 19-24

  Hoehner, Jeff C ^a   Hedborg, Fredrik ^a   Wiklund, Helena Jernberg ^a   Olsen, Leif ^a   Påhlman, Sven ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL;

APOPTOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; FETUS; HUMAN; INFANT; INFANT, NEWBORN; NEUROBLASTOMA; PREGNANCY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T;

EID: 0029020904     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910620106     Document Type: Article

References (34)

1. bcl‐2 gene is highly expressed during neurogenesis in the central nervous system
2. The protooncogene bcl‐2 can selectively rescue neurotrophic‐factor‐dependent neurons from apoptosis
3. In situ neuroblastomas: a contribution to the natural history of neural crest tumors
4. Apoptotic cell death induced by c‐ myc is inhibited by bcl‐2
5. Expression of the apoptosis‐suppressing protein bcl‐2 in neuroblastoma is associated with unfavorable histology and N‐myc amplification
6. Detection of the apoptosis‐suppressing oncoprotein bcl‐2 in hormonerefractory human prostate cancers
7. bcl‐2 inhibits chemotherapy‐induced apoptosis in neuroblastoma
8. A proposed staging for children with neuroblastoma
9. Prevention of programmed cell death of sympathetic neurons by the bcl‐2 protooncogene
10. Identification of programmed cell death in situ via specific labeling of DNA fragmentation
11. bc12 protein is topographically restricted in tissues characterized by apoptotic cell death
12. Steady‐state polypeptide modulations associated with nerve‐growth‐factor(NGF)‐induced terminal differentiation and NGF‐deprivation‐induced apoptosis in human neuroblastoma cells
13. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification
14. Evaluation of the Shimada classification in advanced neuroblastoma with special reference to mitosis karyorrhexis index: a report from the children's cancer study group. Mod
15. Expression of bcl‐2 in fetal tissues suggests a role in morphogenesis
16. bcl‐2 expression in adult and embryonic non‐haematopoietic tissues
17. bcl‐2‐immunoglobulin extended B cell survival and follicular lymphoproliferation
18. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma
19. bcl‐2 heterodimerized in vivo with a conserved homolog, bax, that accelerates programed cell death
20. Identification of mRNAs associated with programmed cell death in immature thymocytes
21. Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death)
22. Differential expression of bcl‐2 in neuroblastoma and other human tumor cell lines of neural origin
23. Histopathological prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age‐linked classification of neuroblastomas
24. Stress‐resistance conferred by high level of bcl‐2 alpha protein in human B‐lymphoblastoid cells
25. Toward an understanding of the molecular mechanisms of physiological cell death
26. bcl‐2 gene promotes haemopoietic cell survival and cooperates with c‐myc to immortalize pre‐B cells
27. bcl‐2‐deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
28. Molecular regulation of apoptosis: genetic controls on cell death
29. Glucocorticoid induced thymocyte apoptosis is associated with endonuclease activation
30. Cell death: the significance of apoptosis